ATYR
aTyr Pharma
ATYR
ATYR
41 hedge funds and large institutions have $61.3M invested in aTyr Pharma in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
41
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.86M | |
| 2 | +$875K | |
| 3 | +$576K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$206K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$199K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$953K | |
| 3 | -$544K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$455K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$175K |